Tri Locum Partners as of Sept. 30, 2025
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 18 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | 12.9 | $56M | 303k | 185.42 | |
| United Therapeutics Corporation (UTHR) | 11.8 | $51M | 122k | 419.21 | |
| Merck & Co (MRK) | 8.6 | $38M | 447k | 83.93 | |
| Axsome Therapeutics (AXSM) | 8.2 | $36M | 292k | 121.45 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 8.0 | $35M | 175k | 198.81 | |
| Vera Therapeutics Cl A (VERA) | 8.0 | $35M | 1.2M | 29.06 | |
| Argenx Se Sponsored Adr (ARGX) | 7.4 | $32M | 43k | 737.56 | |
| Madrigal Pharmaceuticals (MDGL) | 7.1 | $31M | 68k | 458.66 | |
| Soleno Therapeutics (SLNO) | 7.0 | $31M | 451k | 67.60 | |
| Abbvie (ABBV) | 4.8 | $21M | 90k | 231.54 | |
| Korro Bio (KRRO) | 3.7 | $16M | 338k | 47.89 | |
| Xenon Pharmaceuticals (XENE) | 3.4 | $15M | 366k | 40.15 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 2.5 | $11M | 725k | 15.27 | |
| Stevanato Group S P A Ord Shs (STVN) | 2.0 | $8.6M | 333k | 25.75 | |
| Dianthus Therapeutics (DNTH) | 1.7 | $7.2M | 183k | 39.35 | |
| Tarsus Pharmaceuticals (TARS) | 1.6 | $7.1M | 119k | 59.43 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.9 | $4.0M | 76k | 53.00 | |
| Biohaven (BHVN) | 0.5 | $2.2M | 149k | 15.01 |
